Endologix CEO steps down

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
In PersonPolitics & Policy Live: Trade and Sustainability Amidst Volatile Markets
- 04/04/2023
- Convene, 1201 Wilson Blvd, Arlington, VA 22209
- 3:30 PM – 6:30 PM ET
WebinarThe Private Equity Landscape under review: The Middle East and Africa story in 2023
- 04/05/2023
- Live, Online
- 10:00 am - 11:00 am BST
WebinarManaging Investment Risk Amid Market Uncertainty
- 04/05/2023
- Live, Online
- 11:00 am - 12:00 am EST
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Perspectivas América Latina 2023 Emerging Trends & Growth

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

21 Feb, 2018 | 17:04

Author Tayyeba Irum
Theme Healthcare & Pharmaceuticals

John McDermott has decided to step down as CEO of Endologix Inc.

McDermott, who has been the CEO of the Irvine, Calif.-based company since May 2008, will remain in his position until a successor is found to ensure a smooth transition.